Subtle differences in an mRNA sequence enables a ribosome to produce more or less of a certain protein. A new AI model called ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...

The model can be accessed through Latent’s web-based platform for push-button protein design. Sign ups are open now for early access: platform.latentlabs.com Extensive lab validation shows picomolar ...

This study provides valuable findings regarding potential correlates of protection against the African swine fever virus. The evidence supporting the claims is solid, although analysis using a higher ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

Berkeley scientists have developed a smartphone-based biosensor that mimics coffee-ring physics to detect disease proteins ...

Organochlorine pollutants (OCPs), as a class of environmentally persistent and bioaccumulative toxic compounds, pose severe threats to ecosystems and human health. This study developed three novel ...

A computational pipeline for improving antibody-antigen binding affinity through CDR-focused mutations, using AI-based inverse folding (ProteinMPNN), structural modeling (IgFold, AlphaFold-Multimer), ...

Traditional therapeutic antibody development has been constrained by long screening processes, and de novo antibody design requires a deep understanding of how the entire protein sequence affects ...